Mefcom Capital Markets Ltd
Incorporated in 1985, Mefcom Capital Markets Ltd is engaged in capital market operations and merchant banking activities.
- Market Cap ₹ 89.2 Cr.
- Current Price ₹ 19.5
- High / Low ₹ 25.2 / 10.4
- Stock P/E 12.8
- Book Value ₹ 5.39
- Dividend Yield 0.00 %
- ROCE 41.1 %
- ROE 43.3 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company is expected to give good quarter
- Company has delivered good profit growth of 43.3% CAGR over last 5 years
- Company's median sales growth is 74.7% of last 10 years
- Company's working capital requirements have reduced from 54.7 days to 29.0 days
Cons
- Stock is trading at 3.62 times its book value
- Company has a low return on equity of 10.9% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Finance Industry: Finance & Investments
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3 | 2 | 3 | 2 | 6 | 26 | 4 | 3 | 31 | 107 | 66 | 233 | 316 | |
4 | 2 | 2 | 2 | 7 | 25 | 6 | 4 | 28 | 103 | 71 | 224 | 308 | |
Operating Profit | -1 | -0 | 0 | -0 | -0 | 1 | -3 | -2 | 2 | 5 | -5 | 9 | 8 |
OPM % | -29% | -8% | 19% | -1% | -6% | 2% | -70% | -67% | 7% | 4% | -7% | 4% | 3% |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit before tax | -1 | -0 | 0 | -0 | -0 | 1 | -2 | -2 | 2 | 4 | -6 | 9 | 8 |
Tax % | 1% | 0% | 0% | 500% | 9% | 0% | -2% | 0% | 0% | 17% | 0% | 2% | |
-1 | -0 | 0 | -0 | -0 | 1 | -2 | -2 | 2 | 3 | -6 | 8 | 8 | |
EPS in Rs | -0.14 | -0.02 | 0.11 | -0.01 | -0.04 | 0.12 | -0.42 | -0.32 | 0.48 | 0.66 | -1.17 | 1.70 | 1.52 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 66% |
5 Years: | 130% |
3 Years: | 97% |
TTM: | 224% |
Compounded Profit Growth | |
---|---|
10 Years: | 57% |
5 Years: | 43% |
3 Years: | 57% |
TTM: | 345% |
Stock Price CAGR | |
---|---|
10 Years: | 22% |
5 Years: | 56% |
3 Years: | 53% |
1 Year: | 44% |
Return on Equity | |
---|---|
10 Years: | 4% |
5 Years: | 8% |
3 Years: | 11% |
Last Year: | 43% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
Reserves | 1 | 1 | 2 | 0 | 7 | 6 | 2 | 1 | 4 | 9 | 4 | 13 | 16 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 8 | 6 | 1 | 3 | |
2 | 3 | 3 | 2 | 3 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | |
Total Liabilities | 12 | 13 | 13 | 11 | 19 | 18 | 13 | 11 | 18 | 28 | 21 | 25 | 31 |
1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 4 | 4 | 4 | 3 | 9 | 5 | 2 | 2 | 3 | 7 | 6 | 5 | 4 |
7 | 8 | 8 | 6 | 10 | 11 | 11 | 9 | 15 | 21 | 14 | 20 | 26 | |
Total Assets | 12 | 13 | 13 | 11 | 19 | 18 | 13 | 11 | 18 | 28 | 21 | 25 | 31 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-4 | 2 | -1 | -1 | 3 | 1 | -2 | -5 | -4 | -2 | 0 | 3 | |
5 | 0 | 1 | 1 | -3 | -0 | 2 | 6 | 0 | -2 | 1 | 4 | |
-1 | -0 | 0 | -0 | 0 | -0 | 0 | 0 | 3 | 4 | -2 | -6 | |
Net Cash Flow | -1 | 2 | -1 | -1 | -0 | 1 | 0 | 0 | -1 | 0 | -0 | -0 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 19 | 10 | 0 | 84 | 37 | 7 | 35 | 46 | 4 | 1 | 2 | 1 |
Inventory Days | 46 | 0 | 113 | 122 | 333 | 46 | 177 | 546 | 151 | 59 | 62 | 27 |
Days Payable | 24 | 308 | 28 | 16 | 1 | 0 | 2 | 2 | 0 | 2 | 0 | |
Cash Conversion Cycle | 41 | 10 | -195 | 178 | 354 | 53 | 212 | 590 | 153 | 60 | 61 | 28 |
Working Capital Days | 355 | 243 | 238 | 668 | 469 | 70 | 406 | 965 | 156 | 64 | 71 | 29 |
ROCE % | -8% | -1% | 4% | 0% | -3% | 3% | -16% | -15% | 15% | 20% | -20% | 41% |
Documents
Announcements
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
18 Nov - Disclosure of substantial acquisition of shares by Vijay Mehta.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
12 Nov - Copy of Newspaper Publication of Unaudited (Standalone and Consolidated) Financial Results of the Company for the Quarter and Half year ended on 30th September 2024, …
- The Unaudited (Standalone & Consolidated) Financial Results For The Quarter And Half Year Ended On 30Th September 2024 11 Nov
-
Board Meeting Outcome for Outcome Of Board Meeting Of Company Held On 11Th November, 2024
11 Nov - Board approved unaudited financial results for Q2 2024.
-
Board Meeting Intimation for Prior Intimation For The Board Meeting To Be Held For Approval Of Financial Results (Standalone & Consolidated) For Quarter/Half Year Ended On 30Th September, 2024
30 Oct - Board meeting scheduled to approve Q2 financial results.
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2009
from bse
-
Financial Year 2008
from bse
Company Overview:[1]
Company has managed 250+ IPOs & Rights issues, helping mobilize more than INR 25,000 million in Indian Capital Markets.
Company is a widely held public limited company with about 4,000 shareholders including institutional investors such as Unit Trust of India, PNB Mutual Fund, BOI Mutual Fund, Allahabad Bank, Catholic Syrian Bank and more than 250 NRI investors from all over the world.